ArticleMolecular and clinical oncology2016

TP53 mutation is associated with a poor clinical outcome for non-small cell lung cancer: Evidence from a meta-analysis.

Jincui Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.